Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor Activity

Doxorubicin (DOX) is a well-known chemotherapeutic agent extensively applied in the field of cancer therapy. However, similar to other chemotherapeutic agents such as cisplatin, paclitaxel, docetaxel, etoposide and oxaliplatin, cancer cells are able to obtain chemoresistance that limits DOX efficacy...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Pharmaceutics
Hoofdauteurs: Ashrafizadeh, Milad, Zarrabi, Ali, Hashemi, Farid, Zabolian, Amirhossein, Saleki, Hossein, Bagherian, Morteza, Azami, Negar, Bejandi, Atefe Kazemzade, Hushmandi, Kiavash, Ang, Hui Li, Makvandi, Pooyan, Khan, Haroon, Kumar, Alan Prem
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI 2020
Onderwerpen:
Review
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7697177/
https://ncbi.nlm.nih.gov/pubmed/33187385
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12111084
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items